The transformation of simple hydrocarbons into more complex and valuable products has revolutionised modern synthetic chemistry. This type of reactivity has quickly become one of the cornerstones of modern catalysis . 5631-96-9, Name is 2-(2-Chloroethoxy)tetrahydro-2H-pyran, molecular formula is C7H13ClO2. In a Patent，once mentioned of 5631-96-9, Reference of 5631-96-9
The invention discloses a nitrogen-containing heterocyclic derivatives and their angiogenesis diseases of the retina in the application, the nitrogen-containing heterocyclic derivatives is the formula Wherein R1 , R2 , R3 , R4 Independently selected from – H or – CN. In the 5 mug/mL under the same concentration, the implementation of the example two, implementation […] HRCEC […] and implementation of growth inhibition rate of the superior to the monoclonal antibody medicine Avastin. To the intravitreal injection after administration, the compounds of the invention can reduce the pathological neovascularization, illustrate the invention nitrogen-containing heterocyclic […] I or the salts thereof can be used for the treatment of retinal angiogenesis related diseases in-depth research and development, the diseases such as retinal vein occlusion, shelter for diabetic retinopathy, retinal new blood vessel membrane, neovascular glaucoma, premature retinopathy, such as proliferative vitreoretinopathy. (by machine translation)
Reference of 5631-96-9, In the meantime we’ve collected together some recent articles in this area about Reference of 5631-96-9 to whet your appetite. Happy reading!
Reference：
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics